Hosted on MSN37m
Wedbush Downgrades Keros Therapeutics (KROS)Fintel reports that on January 17, 2025, Wedbush downgraded their outlook for Keros Therapeutics (NasdaqGM:KROS) from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback